Advertisement
Abstract| Volume 45, SUPPLEMENT 2, S65, November 2022

Utility of PSA density for the selection of patients undergoing MRI before first prostate biopsy to optimize prostate cancer diagnosis

Open AccessDOI:https://doi.org/10.1016/S2666-1683(22)02467-3
Utility of PSA density for the selection of patients undergoing MRI before first prostate biopsy to optimize prostate cancer diagnosis
Previous ArticleThe diagnostic added value of PSMA PET/CT in men with newly diagnosed ISUP grade group 3 prostate cancer
Next ArticleImmunohistochemical PSMA expression and histology predictors in primary staging high-risk prostate cancer patients studied with PSMA PET/CT
      This paper is only available as a PDF. To read, Please Download here.

      Article info

      Identification

      DOI: https://doi.org/10.1016/S2666-1683(22)02467-3

      Copyright

      © 2022 European Association of Urology. Published by Elsevier B.V. Published by Elsevier Inc.

      User license

      Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article (private use only, not for distribution)
      • Reuse portions or extracts from the article in other works

      Not Permitted

      • Sell or re-use for commercial purposes
      • Distribute translations or adaptations of the article

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX